MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas

Cancer Prevention Research

Volumn 8, Issue 11, 2015, Pages 1112-1119

  Taguchi, Ayumu ^a   Rho, Jung Hyun ^b   Yan, Qingxiang ^a   Zhang, Yuzheng ^b   Zhao, Yang ^a   Xu, Hanwen ^a   Tripathi, Satyendra Chandra ^a   Wang, Hong ^a   Brenner, Dean E ^c,d   Kucherlapati, Melanie ^e   Kucherlapati, Raju ^e   Boutin, Adam T ^a   Wang, Y Alan ^a   DePinho, Ronald A ^a   Feng, Ziding ^a   Lampe, Paul D ^b   Hanash, Samir M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AK1 PROTEIN; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CLIC1 PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; MAPRE1 PROTEIN; UNCLASSIFIED DRUG; ADENYLATE KINASE; ADENYLATE KINASE 1; MAPRE1 PROTEIN, HUMAN; MAPRE1 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; EARLY CANCER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; VALIDATION STUDY; ADENOMA; ANIMAL; BLOOD; CASE CONTROL STUDY; COLORECTAL TUMOR; MASS SPECTROMETRY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; TUMOR CELL LINE;

ADENOMA; ADENYLATE KINASE; ANIMALS; BIOMARKERS, TUMOR; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MASS SPECTROMETRY; MICE; MICROTUBULE-ASSOCIATED PROTEINS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 84946116693     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0077     Document Type: Article

References (47)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64:104-17.
2. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014;383:1490-502.
3. Valori R, Rey JF, Atkin WS, Bretthauer M, Senore C, Hoff G, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Quality assurance in endoscopy in colorectal cancer screening and diagnosis. Endoscopy 2012;44:SE88-105.
4. Kuipers EJ, Rosch T, Bretthauer M. Colorectal cancer screening-optimizing current strategies and new directions. Nat Rev Clin Oncol 2013;10:130-42.
5. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. NEngl J Med 2014;370:1287-97.
6. Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 2014;63:317-25.
7. Kyro C, Olsen A, Landberg R, Skeie G, Loft S, Aman P, et al. Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancer. J Natl Cancer Inst 2014;106:djt352.
8. Van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, Jansen EH, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 2011;60:1094-102.
9. Fijneman RJ, De Wit M, Pourghiasian M, Piersma SR, Pham TV, Warmoes MO, et al. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer. Clin Cancer Res 2012;18:2613-24.
10. Tan E, Gouvas N, Nicholls RJ, Ziprin P, Xynos E, Tekkis PP. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 2009;18:15-24.
11. Duffy MJ, Van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur JCancer 2007;43:1348-60.
12. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;5:845-56.
13. Duffy MJ. Carcinoembryonic antigen as amarker for colorectal cancer: is it clinically useful? Clin Chem 2001;47:624-30.
14. Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, et al. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prev Res 2012;5:655-64.
15. Green RA, Wollman R, Kaplan KB. APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment. Mol Biol Cell 2005;16:4609-22.
16. Su LK, Burrell M, Hill DE, Gyuris J, Brent R, Wiltshire R, et al. APC binds to the novel protein EB1. Cancer Res 1995;55:2972-7.
17. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001;1:55-67.
18. Wen Y, Eng CH, Schmoranzer J, Cabrera-Poch N, Morris EJ, Chen M, et al. EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol 2004;6:820-30.
19. Faca V, Coram M, Phanstiel D, Glukhova V, Zhang Q, Fitzgibbon M, et al. Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. J Proteome Res 2006;5:2009-18.
20. Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faca VM, Kelly-Spratt K, et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 2011;20:289-99.
21. Ong SE, Mann M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc 2006;1:2650-60.
22. Loch CM, Ramirez AB, Liu Y, Sather CL, Delrow JJ, Scholler N, et al. Use of high density antibody arrays to validate and discover cancer serum biomarkers. Mol Oncol 2007;1:313-20.
23. Ramirez AB, Loch CM, Zhang Y, Liu Y, Wang X, Wayner EA, et al. Use of a single-chain antibody library for ovarian cancer biomarker discovery. Mol Cell Proteomics 2010;9:1449-60.
24. Etzioni R, Kooperberg C, Pepe M, Smith R, Gann PH. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics 2003;4:523-38.
25. Mc NQ. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947;12:153-7.
26. Kucherlapati MH, Esfahani S, Habibollahi P, Wang J, Still ER, Bronson RT, et al. Genotype directed therapy in murine mismatch repair deficient tumors. PloS One 2013;8:e68817.
27. Stypula-Cyrus Y, Mutyal NN, Dela Cruz M, Kunte DP, Radosevich AJ, Wali R, et al. End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis. FEBS Lett 2014;588:829-35.
28. Sugihara Y, Taniguchi H, Kushima R, Tsuda H, Kubota D, Ichikawa H, et al. Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer. J Proteomics 2012;75:5342-55.
29. Yegutkin GG, Wieringa B, Robson SC, Jalkanen S. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities. FASEB J 2012;26:3875-83.
30. Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010;29:5346-58.
31. Dzeja P, Terzic A. Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int J Mol Sci 2009;10:1729-72.
32. Hittel DS, Hathout Y, Hoffman EP, Houmard JA. Proteome analysis of skeletal muscle from obese and morbidly obese women. Diabetes 2005;54:1283-8.
33. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86:s836-42.
34. Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, et al. Proteogenomic characterization of human colon and rectal cancer. Nature 2014;513:382-7.
35. Petrova DT, Asif AR, Armstrong VW, Dimova I, Toshev S, Yaramov N, et al. Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. Clin Biochem 2008;41:1224-36.
36. Wang P, Zeng Y, Liu T, Zhang C, Yu PW, Hao YX, et al. Chloride intracellular channel 1 regulates colon cancer cell migration and invasion through ROS/ERK pathway. World J Gastroenterol 2014;20:2071-8.
37. Chang YH, Wu CC, Chang KP, Yu JS, Chang YC, Liao PC. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma. J Proteome Res 2009;8:5465-74.
38. Skrzycki M, Majewska M, Podsiad M, Czeczot H. Expression and activity of superoxide dismutase isoenzymes in colorectal cancer. Acta biochimica Polonica 2009;56:663-70.
39. Amaral EG, Fagundes DJ, Marks G, Inouye CM. Study of superoxide dismutase's expression in the colon produced by azoxymethane and inositol hexaphosfate's paper, in mice. Acta Cir Bras 2006;21:27-31.
40. Christudoss P, Selvakumar R, Pulimood AB, Fleming JJ, Mathew G. Tissue zinc levels in precancerous tissue in the gastrointestinal tract of azoxymethane (AOM)-treated rats. Exp Toxicol Pathol 2008;59:313-8.
41. Korenaga D, Takesue F, Kido K, Yasuda M, Inutsuka S, Honda M, et al. Impaired antioxidant defense system of colonic tissue and cancer development in dextran sulfate sodium-induced colitis in mice. J Surg Res 2002;102:144-9.
42. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 2014;6:224ra24.
43. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009;58:1375-81.
44. Hofsli E, Sjursen W, Prestvik WS, Johansen J, Rye M, Trano G, et al. Identification of serum microRNA profiles in colon cancer. Br J Cancer 2013;108:1712-9.
45. Barderas R, Villar-Vazquez R, Fernandez-Acenero MJ, Babel I, Pelaez-Garcia A, Torres S, et al. Sporadic colon cancer murine models demonstrate the value of autoantibody detection for preclinical cancer diagnosis. Sci Rep 2013;3:2938.
46. Chang W, Wu L, Cao F, Liu Y, Ma L, Wang M, et al. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma. Clin Cancer Res 2011;17:5715-24.
47. Leufkens AM, Van Duijnhoven FJ, Woudt SH, Siersema PD, Jenab M, Jansen EH, et al. Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested case-control study in the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol 2012;175:653-63.